EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study

Bomi Yi, Cholong Kim, Young-Jin Lee, Sae Byul Lee, Il Yong Chung, Hee Jeong Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Tae-Kyung Robyn Yoo, Jisun Kim

Breast Cancer Research and Treatment · 2026-11 · 220 (1)

DOI: 10.1007/s10549-026-08082-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 04.11.2026. Verfasst von Bomi Yi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Se…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Asymptomatic Diseases. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Although early-stage breast cancer incidence has increased following Korea's National Cancer Screening Program, the number of breast cancer-related deaths continues to rise, and many patients still present with symptoms. We investigated the clinicopathological characteristics and long-term prognosis of symptomatic versus asymptomatic breast cancer to determine whether symptomatic presentation serves as an independent prognostic factor. METHODS: In this single-center, retrospective cohort study, we analyzed 38,050 women who underwent surgery for primary invasive breast cancer (1994-2021). Patients were categorized into symptomatic (N = 24,305) and asymptomatic (N = 13,745) groups. We used multivariable Cox models to adjust for confounders and conducted interaction analyses to assess prognostic factors and the impact of symptom presentation. RESULTS: Symptomatic patients were significantly younger than asymptomatic patients and presented with more advanced stages and aggressive biological features. Symptomatic presentation was associated with a significantly lower 10-year recurrence-free interval (P < 0.001). In multivariable analysis, symptomatic status remained an independent predictor of worse outcomes (hazard ratio for recurrence, 1.44; 95% confidence interval, 1.33 to 1.57). Interaction analyses across subgroups defined by operation period, molecular subtype, and pathologic stage consistently showed that symptomatic presentation conferred a significantly higher risk of recurrence. CONCLUSION: Symptomatic breast cancer represents a clinically distinct presentation associated with adverse clinicopathologic features and persistently poorer long-term outcomes, even after adjustment for established prognostic factors. Despite the benefits of screening, the persistent burden of symptomatic disease underscores the need for public health strategies focused on early symptom awareness and regular breast self-examination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm Recurrence, LocalAsymptomatic DiseasesHumansFemaleRetrospective StudiesPrognosisMiddle AgedNeoplasm StagingAgedAdultRepublic of Korea

Stichwörter der Autor:innen

Breast cancerEarly detectionMolecular subtypesScreen-detected breast cancerSymptomatic presentation

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
  • Department of Surgery, Armed Forces Medical Center, Seongnam, Korea.
  • Department of Plastic and Reconstructive Surgery, The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si, Gyeonggi-do, Republic of Korea.
  • Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. tkyoo@amc.seoul.kr.
  • Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. jisunkim@amc.seoul.kr.

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Yi, B., Kim, C., Lee, Y. J., Lee, S. B., Chung, I. Y., Kim, H. J., Ko, B. S., Lee, J. W., Son, B. H., Yoo, T. R., & Kim, J. (2026). Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study. Breast Cancer Research and Treatment, 220(1). https://doi.org/10.1007/s10549-026-08082-5

Vancouver

Yi B, Kim C, Lee YJ, Lee SB, Chung IY, Kim HJ, et al. Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study. Breast Cancer Research and Treatment. 2026;220(1). doi:10.1007/s10549-026-08082-5

BibTeX
@article{Yi2026,
  author = {Yi, Bomi and Kim, Cholong and Lee, Young-Jin and Lee, Sae Byul and Chung, Il Yong and Kim, Hee Jeong and Ko, Beom Seok and Lee, Jong Won and Son, Byung Ho and Yoo, Tae-Kyung Robyn and Kim, Jisun},
  title = {Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  volume = {220},
  number = {1},
  doi = {10.1007/s10549-026-08082-5}
}
Kostenlos starten →